Letter to the Editor

British Journal of Cancer (2007) 96, 1623–1624. doi:10.1038/sj.bjc.6603742 www.bjcancer.com
Published online 17 April 2007

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

P de Graeff1, J Hall2, A P G Crijns1, G H de Bock3, J Paul2, K A ten Hoor1, S de Jong4, H Hollema5, J M S Bartlett6, R Brown2,7 and A G J van der Zee1

  1. 1Department of Gynaecologic Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  2. 2Cancer Research UK Beatson Laboratories, Centre for Oncology and Applied Pharmacology, University of Glasgow, Scotland, UK
  3. 3Department of Epidemiology and Statistics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  4. 4Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  5. 5Department of Pathology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  6. 6Endocrine Cancer Group, University Department of Surgery, Royal Infirmary, Glasgow, Scotland, UK

Correspondence: R Brown, E-mail: R.Brown@beatson.gla.ac.uk

7On behalf of the Scottish Gynaecological Clinical Trials Group.